United Therapeutics | Zysk Brutto Na Sprzedaży



Gross Profit On Sales Zmiana Data
Amarin USD 16.28M 26.49M 2024-09
Ardelyx USD 97.86M 15.35M 2024-12
Baxter International USD 1.02B 19M 2024-12
Bayer EUR 6.01B 1.13B 2024-12
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 611.17M 53.89M 2024-12
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.56B 57M 2024-12
Halozyme Therapeutics USD 255.95M 15.3M 2024-12
Insmed USD 78.29M 6.04M 2024-12
Intra Cellular Therapies USD 178.82M 18.75M 2024-12
Ionis Pharmaceuticals USD 222.75M 90M 2024-12
J&J USD 15.41B 102M 2024-12
Moderna USD 420M 1.14B 2024-12
Pfizer USD 12.11B 718M 2024-12
PTC Therapeutics USD 196.89M 10.95M 2024-12
Regeneron Pharmaceuticals USD 3.22B 1.88B 2024-12
Sarepta Therapeutics USD 526.11M 150.63M 2024-12
Teva Pharmaceutical Industries USD 2.12B 85M 2024-12
United Therapeutics USD 660M 5.8M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



United Therapeutics Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.